AbbVie's office in Belgium: avenue Einstein , B Wavre

Business Address: avenue Einstein 14, B-1300 Wavre

Phone: +3210477811

Web: https://www.abbvie.be

Type Public company
Traded as
  • NYSE: ABBV
  • S&P 100 component
  • S&P 500 component
Industry Biopharmaceutical
Founded 2013 (2013)
Headquarters North Chicago, Illinois, U.S.
Area served Worldwide
(170+ countries)
Key people Richard A. Gonzalez
(Chairman and CEO)
Michael Severino
(Vice Chairman and President)
Products Pharmaceutical drugs
  • Humira (adalimumab)
  • Imbruvica (ibrutinib)
  • Venclexta (venetoclax)
  • Zinbryta (daclizumab)
  • Kaletra (lopinavir)
  • Norvir (ritonavir)
  • Mavyret/Maviret (glecaprevir/pibrentasvir)
  • Skyrizi (risankizumab)
  • Rinvoq (upadacitinib)
Revenue Increase US$56.20 billion (2021)
Operating income Decrease US$17.92 billion (2021)
Net income Decrease US$11.54 billion (2021)
Total assets Decrease US$146.53 billion (2021)
Total equity Increase US$15.44 billion (2021)
Number of employees Increase 50,000 (Jan 2022)
Website abbvie.com

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company. Our ~47,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions. We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself. At AbbVie, we see a future full of possibility, where health is in reach and patient lives are improved. See our employees, our science and our hope for tomorrow

AbbVie's locations around the world

3
Subscribe